[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581462":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":11,"centralContacts":11,"locations":26,"responsibleParty":216,"collaborators":11,"id":218,"slug":11,"hasResults":219,"nctId":220,"briefTitle":221,"officialTitle":222,"acronym":223,"eligibilityCriteria":224,"healthyVolunteers":219,"sex":225,"minAge":226,"maxAge":11,"enrollmentInfo":227,"targetDuration":11,"studyType":230,"phases":231,"briefSummary":233,"conditions":234,"keywords":236,"overallStatus":29,"whyStopped":11,"lastUpdateSubmitDate":246,"lastUpdatePostDateStruct":247,"startDateStruct":250,"completionDateStruct":252,"leadSponsor":254,"locationsCount":255},{"fullName":5,"class":6},"EXACT Therapeutics AS","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Acoustic Cluster Therapy (ACT) with mFOLFIRINOX","EXPERIMENTAL",null,[13,14],"Combination Product: Acoustic Cluster Therapy","Drug: Modified FOLFIRINOX",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":11},"COMBINATION_PRODUCT","Acoustic Cluster Therapy","Drug: PS101; Device: Ultrasound",[9],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":11},"DRUG","Modified FOLFIRINOX","Chemotherapy",[9],[27,49,69,86,103,122,140,159,179,196],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"HonorHealth Research Institute","RECRUITING","Scottsdale","Arizona","85258","United States",{"type":35,"coordinates":36},"Point",[37,38],-111.89903,33.50921,{"lat":38,"lon":37},[41,46],{"name":42,"role":43,"phone":44,"phoneExt":11,"email":45},"Lu Study Coordinator","CONTACT","(+1) (480) 323 1364","clinicaltrials@honorhealth.com, lzhao@honorhealth.com",{"name":47,"role":48,"phone":11,"phoneExt":11,"email":11},"Erkut Borazanci, MD","PRINCIPAL_INVESTIGATOR",{"facility":50,"status":29,"city":51,"state":52,"zip":53,"country":33,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Stanford Cancer Center Palo Alto","Stanford","California","94305",{"type":35,"coordinates":55},[56,57],-122.16608,37.42411,{"lat":57,"lon":56},[60,64,67],{"name":61,"role":43,"phone":62,"phoneExt":11,"email":63},"Britney Williams","650-736-3688","bw718@stanford.edu",{"name":65,"role":43,"phone":11,"phoneExt":11,"email":66},"Isabel Leonio ( Study Coordinator)","ileonio@stanford.edu",{"name":68,"role":48,"phone":11,"phoneExt":11,"email":11},"Pejman Ghanouni, MD:PhD",{"facility":70,"status":29,"city":71,"state":72,"zip":73,"country":33,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"Beth Israel Deaconess Medical Center - Division of Hematology\u002FOncology","Boston","Massachusetts","02215",{"type":35,"coordinates":75},[76,77],-71.05977,42.35843,{"lat":77,"lon":76},[80,84],{"name":81,"role":43,"phone":82,"phoneExt":11,"email":83},"Selma Sinanovic Study Coordinator","+1 617-975-7411","ssinanov@bidmc.harvard.edu",{"name":85,"role":48,"phone":11,"phoneExt":11,"email":11},"Andrea Bullock, MD",{"facility":87,"status":29,"city":88,"state":89,"zip":90,"country":33,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"Henry Ford Centre","Detroit","Michigan","48202",{"type":35,"coordinates":92},[93,94],-83.04575,42.33143,{"lat":94,"lon":93},[97,101],{"name":98,"role":43,"phone":99,"phoneExt":11,"email":100},"Christina Vu, Study Nurse","+1 313-556-8107","cvu1@hfhs.org",{"name":102,"role":48,"phone":11,"phoneExt":11,"email":11},"Maria Diab, MD",{"facility":104,"status":29,"city":105,"state":106,"zip":107,"country":33,"cosmosGeoPoint":108,"geoPoint":112,"contacts":113},"Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital","Philadelphia","Pennsylvania","19107",{"type":35,"coordinates":109},[110,111],-75.16362,39.95238,{"lat":111,"lon":110},[114,118,121],{"name":115,"role":43,"phone":116,"phoneExt":11,"email":117},"Babar Bashir, MD","(215) 955-4279","Babar.Bashir@jefferson.edu",{"name":119,"role":43,"phone":116,"phoneExt":11,"email":120},"Priscilla Machado -Sub Investigator, MD, FAIUM","priscilla.machado@jefferson.edu",{"name":115,"role":48,"phone":11,"phoneExt":11,"email":11},{"facility":123,"status":29,"city":124,"state":106,"zip":125,"country":33,"cosmosGeoPoint":126,"geoPoint":130,"contacts":131},"Allegheny General Hospital","Pittsburgh","15212",{"type":35,"coordinates":127},[128,129],-79.99589,40.44062,{"lat":129,"lon":128},[132,136,139],{"name":133,"role":43,"phone":134,"phoneExt":11,"email":135},"Paul Renz, DO","+1-412-359-3400","paul.renz@ahn.org",{"name":137,"role":43,"phone":11,"phoneExt":11,"email":138},"Linda Kernrick (Study Coordinator)","linda.kernick@ahn.org",{"name":133,"role":48,"phone":11,"phoneExt":11,"email":11},{"facility":141,"status":29,"city":142,"state":143,"zip":144,"country":33,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"Brown University Cancer Institute","Providence","Rhode Island","02906",{"type":35,"coordinates":146},[147,148],-71.41283,41.82399,{"lat":148,"lon":147},[151,155,158],{"name":152,"role":43,"phone":153,"phoneExt":11,"email":154},"Alexander Raufi, MD","+1 (844) 222-2881","ARaufi2@brownhealth.org",{"name":156,"role":43,"phone":11,"phoneExt":11,"email":157},"Lindsey Cavanagh Study Nurse","lcavanagh@brownhealth.org",{"name":152,"role":48,"phone":11,"phoneExt":11,"email":11},{"facility":160,"status":29,"city":161,"state":161,"zip":162,"country":163,"cosmosGeoPoint":164,"geoPoint":168,"contacts":169},"CAMBRIDGE CANCER TRIALS CENTRE-Addenbrooke's Hospital","Cambridge","CB2 0QQ","United Kingdom",{"type":35,"coordinates":165},[166,167],0.11667,52.2,{"lat":167,"lon":166},[170,174,177],{"name":171,"role":43,"phone":172,"phoneExt":11,"email":173},"Emma Wong Team Co-Lead for Aerodigestive, HPB, Head & Neck Trials Team","+44(0)1223 216083","emma.wong1@nhs.net",{"name":175,"role":43,"phone":172,"phoneExt":11,"email":176},"Joanne Mayhew Research Nurse","joanne.mayhew1@nhs.net",{"name":178,"role":48,"phone":11,"phoneExt":11,"email":11},"Kiran Purushothaman, MD",{"facility":180,"status":29,"city":181,"state":182,"zip":183,"country":163,"cosmosGeoPoint":184,"geoPoint":188,"contacts":189},"Gary Weston Centre- Imperial College Healthcare- Du Cane Road","Hammersmith","London","W12 0HS",{"type":35,"coordinates":185},[186,187],-0.22882,51.49384,{"lat":187,"lon":186},[190,194],{"name":191,"role":43,"phone":192,"phoneExt":11,"email":193},"Richard Senior Clinical Research Practitioner","+44 (0)203 313 8367","richard.elliott2@nhs.net",{"name":195,"role":48,"phone":11,"phoneExt":11,"email":11},"Harpreet Wasan, Professor: MBBS:MRCP",{"facility":197,"status":29,"city":198,"state":199,"zip":200,"country":163,"cosmosGeoPoint":201,"geoPoint":205,"contacts":206},"The Royal Marsden- Downs Road","Sutton","Surrey","SM2 5PT",{"type":35,"coordinates":202},[203,204],-0.2,51.35,{"lat":204,"lon":203},[207,211,214],{"name":208,"role":43,"phone":209,"phoneExt":11,"email":210},"Lucy Scott Senior Clinical Trial Coordinator","+44 (0)20 3186 5541","Lucy.Scott@rmh.nhs.uk",{"name":212,"role":43,"phone":209,"phoneExt":11,"email":213},"Hazel Lotte Principal Investigator","Hazel.Lote@rmh.nhs.uk",{"name":215,"role":48,"phone":11,"phoneExt":11,"email":11},"Hazel Lote, MD",{"type":217,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100581462",false,"NCT06850623","Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer","A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer","ENACT","Inclusion Criteria:\n\n* Not deemed suitable for primary curative surgery and have radiographic and pathological disease consistent with inoperable LAPC or borderline resectable pancreatic cancer.\n* Suitable to receive treatment with mFOLFIRINOX according to the Investigator's assessment.\n\nExclusion Criteria:\n\n• Any prior anti-cancer treatment for pancreatic cancer (e.g. chemotherapy, surgery, radiation). Palliative bypass procedure and bile duct stenting are allowed.","ALL","18 Years",{"count":228,"type":229},25,"ESTIMATED","INTERVENTIONAL",[232],"PHASE2","The purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer.",[235],"Locally Advanced Pancreatic Adenocarcinoma",[237,238,239,240,241,242,243,244,18,245],"pancreatic cancer","PS101","ultrasound","microbubbles","Pancreatic Ductal Carcinoma","locally advanced pancreatic cancer","first line treatment","chemotherapy","mFOLFIRINOX","2026-03-30",{"date":248,"type":249},"2026-04-03","ACTUAL",{"date":251,"type":249},"2025-06-19",{"date":253,"type":229},"2027-07-15",{"name":5,"class":6},10]